ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2496

HLA-B27 Influence On The Gut Microbiome

Robert D. Inman1, Aifeng Lin2, Phillip Sherman3 and Lee Pinnell4, 1Dept of Medicine/Rheumatology, Toronto Western Research Institute, University Health Network and University of Toronto, Toronto, ON, Canada, 2Medicine/Rheumatology, Toronto Western Research Institute and University Health Network, Toronto, ON, Canada, 3Pediatrics, Hospital for Sick Children, Toronto, ON, Canada, 4Hospital for Sick Children, Toronto, ON, Canada

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Immunogenetics, microbiome and spondylarthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Spondyloarthropathies and Psoriatic Arthritis: Pathogenesis, Etiology, Animal Models II

Session Type: Abstract Submissions (ACR)

Background/Purpose:  The interrelationship between the gut microbiome and spondyloarthritis (SpA) has been highlighted by recent findings of (i) Subclinical bowel inflammation in SpA  (ii) Antimicrobial serology in AS which is comparable to inflammatory bowel disease (IBD) (iii) The association of HLA-B27 with chronicity in post-Salmonella reactive arthritis. This has raised the important unanswered question whether the HLA-B27 may influence disease susceptibility by an influencing the gut microbiome.

Methods: MHC-I transgenic mice were generated on a background of deleted endogenous MHC-I (DKO) and are designated by the transgenic allele: B27tg, B7tg, and A2tg, and compared with C57BL6 (WT). Mice were challenged with Salmonella typhimurium (5 x 107 organisms) by gavage and followed to establish differential host responses.  Selected mice were euthanized at 24, 48 and 72 hr after infection. Colons were collected for H&E staining. Spleen, liver and mesenteric lymph nodes were dissected and cytokine gene expression determined by real-time PCR. At baseline and at selected time points, colonic contents were collected for analysis of the gut microbioata with primer sets specific for universal bacteria, g-proteobacteria, β-proteobacteria, bacteroidetes, firmicutes, and actinobacteria.

Results: Survival curves after oral Salmonella challenge indicated that the B27tg mouse demonstrated improved survival compared with B7tg and A2tg mice (Fig. 1).  Review of colon pathology, however, revealed no significant differences in the degree of colonic inflammation. Cytokine profiling in mesenteric lymph nodes at 72hr post-challenge showed that B7tg mice expressed less IFN-g and IL-10 and B27 expressed less Foxp3 than respective tg controls. Analysis of the gut microbioal composition at baseline prior to infectious challenge revealed differences related to the MHC-I profile of the mouse: colonization by b-Proteobacteria was enhanced in the B27tg mouse compared with B7tg and A2tg as well as with the DKO and WT control mice (Fig. 2).

Conclusion: Class I MHC expression influences survival and host immune response to oral S. typhimurium challenge in an allele-specific manner.  The endogenous gut microbial profile was distinctively different in B7tg mice, suggesting that the HLA-B27 status directly influences the composition of the gut microbiome. This raises the possibility that the clinical interface between SpA and IBD could be mediated by an interplay between host MHC and the gut microflora.

 


Disclosure:

R. D. Inman,
None;

A. Lin,
None;

P. Sherman,
None;

L. Pinnell,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/hla-b27-influence-on-the-gut-microbiome/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology